Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial – Endpoints News
Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial Endpoints NewsRoche unveils data behind BTK inhibitor’s phase 3…
Gene therapy trial death unnerves promising area of brain research
Gene therapy researchers were converging on a holy grail. A few years ago, researchers at labs and companies…
10 Healthcare Industry Predictions For 2026
The year 2026 will be a year of tumult in American healthcare. Getty Images As December kicks off,…
Ozempic-style drugs should be available to all, not just the rich, says WHO – POLITICO
The WHO wants pharma companies to consider tiered pricing (lower prices in lower-income countries) and voluntary licensing of…
Trump admin claims win as UK bows to pressure on NHS drug spending – POLITICO
The new NICE threshold will be £25,000 to £35,000 per quality adjusted life year gained over and above…
Are we all living inside an AI bubble? Inside circular deals and the quiet financial loop they created
Three years ago, generative AI was barely on anyone’s radar. Three months ago, circular deals were whispered about…
Merck’s experimental pill lowered bad cholesterol as much as shots
Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach…
Redefining nutraceuticals with new delivery formats and pharma-grade standards
The boundaries between pharmaceuticals and nutraceuticals continue to blur. This year’s CPHI 2025 trade show highlighted innovations that…
Trump’s approach to lowering drug costs is raising questions
The Trump administration is turning to an unconventional approach to lowering drug prices in the United States: striking deals…
Leader in addiction medicine issues warning on gambling, MOUD access
BOSTON — The president of a leading addiction medicine group issued stark warnings on hardline Trump administration policies…
Ireland’s ‘Viagra Village’ in the eye of Trump’s tariff storm – politico.eu
Ireland’s ‘Viagra Village’ in the eye of Trump’s tariff storm politico.euWhat Trends Are You Seeing in Pharma Commercialization? PharmExecIreland faces…
FDA rejects Rexulti-Zoloft combo for PTSD
The FDA rejected Otsuka and Lundbeck’s Rexulti and Zoloft combination treatment for PTSD, months after raising concerns about…